Post Approval & Life Cycle Management in the UK

Our UK team manages the full regulatory product life cycle for medicinal products, from initial marketing authorisation through post-approval maintenance, variations, renewals, and lifecycle strategy. We operate within the UK’s standalone regulatory framework and support both national procedures and reliance pathways such as the International Recognition Procedure (IRP).

We work across UK-only and global programmes, ensuring alignment while managing divergence between UK and EU regulatory requirements.

Note: The UK is no longer part of the EU regulatory system. All lifecycle activities must be managed under MHRA procedures, even where EU authorizations exist in parallel.

For initial marketing authorization, see Marketing Authorization Applications in the UK. For product information and labelling, see Product Information, Labelling & Promotional Compliance in the UK. For our full post-approval methodology across all markets, see Post-Approval & Lifecycle Management.

UK Regulatory Landscape

The UK operates an independent regulatory framework for medicinal products under the MHRA. While historically derived from EU legislation, regulatory practice has diverged in several important ways post-Brexit.

National Lifecycle Management

Marketing authorisations are granted and maintained through UK national procedures. All post-authorisation activities, including variations, renewals, and safety updates, are submitted directly to the MHRA.

International Recognition Procedure (IRP)

The IRP allows the MHRA to rely on prior approvals from recognised reference regulators to support UK authorisations. It is used for both initial approvals and certain lifecycle activities.

Post-Brexit Divergence

The UK now operates separate submission pathways, timelines, and product information requirements compared to the EU.

What We Handle Locally

  • Regulatory strategy and lifecycle planning
  • Marketing authorisations and IRP submissions
  • Variations management
  • Renewals and maintenance
  • Product information lifecycle
  • Safety updates and regulatory commitments
  • Regulatory operations and submissions

Our UK Team

Our UK regulatory team includes specialists in lifecycle management, IRP submissions, variation handling, and MHRA interactions.

UK-Specific Considerations by Activity

Activity UK-Specific Considerations
Initial marketing authorisation National or IRP routes
Variations Independent UK submissions
Renewals UK-specific process
Product information UK-specific requirements
Lifecycle strategy Parallel UK/EU planning

UK Experience with IRP and Lifecycle Management

We support integration of IRP into global strategies, manage divergence between UK and EU requirements, and deliver full lifecycle regulatory support from initial approval through post-authorisation maintenance.

Need Support With Your UK Post-Approval Regulatory Programme?

Tell us about your portfolio and we will outline how we can help.

Contact Us

Frequently Asked Questions (FAQ)

What is product lifecycle management in the UK?

All regulatory activities from authorisation through post-approval maintenance, including variations and renewals.

What is the IRP?

A UK reliance pathway based on approvals from recognised regulators.

Do we need separate UK lifecycle management?

Yes, the UK operates independently from the EU.

How are UK variations handled?

They are submitted directly to the MHRA.

How does IRP fit into lifecycle management?

It is used for approvals but followed by standard UK lifecycle requirements.